AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
🇹🇳
TRASTUZUMAB in Tunisia
5 products registered with DPM — 0 active, 5 expired
| Brand / Product | Reg. No. | Holder | Status | Expires |
|---|---|---|---|---|
| HERZUMA Poudre pour solution à diluer pour perfusion / 150 mg | 6653781H | HIKMA Pharmaceuticals | expired | 9 Sept 2022 |
| HERZUMA Poudre pour solution à diluer pour perfusion / 440 mg | 6653782H | HIKMA Pharmaceuticals | expired | 9 Sept 2022 |
| HERTRAZ Pdre p.prep.injectable / 150 mg | 20343011H | MYLAN PHARMACEUTICALS PRIVATE LIMITED | expired | 12 Mar 2018 |
| HERTRAZ Pdre p.prep.injectable / 440 mg | 20343012H | MYLAN PHARMACEUTICALS PRIVATE LIMITED | expired | 12 Mar 2018 |
| HERCEPTIN Pdre p.prep.injectable / 150 mg | 6993151H | Roche Pharma (Schweiz) AG | expired | 30 Apr 2008 |
TRASTUZUMAB — DPM Registration Details
DPM (Tunisia) has 5 registered products containing TRASTUZUMAB, of which 0 are currently active. Data is sourced directly from the official DPM drug register and refreshed daily.
Track TRASTUZUMAB registration expiry dates, monitor competitor approvals, and receive alerts when registration status changes. Create a free account to set up portfolio monitoring.